In this prognostic study, the [18F]-MK-6240 tau-PET tracer showed strong prognostic utility as an accurate predictor of longitudinal cognitive change, especially in cognitively unimpaired individuals during the preclinical stage of Alzheimer’s disease. The gene discussed is MAPT; the disease is Alzheimer disease.